Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.

PubWeight™: 5.77‹?› | Rank: Top 1%

🔗 View Article (PMC 156298)

Published in Proc Natl Acad Sci U S A on April 28, 2003

Authors

Maya K Leabman1, Conrad C Huang, Joseph DeYoung, Elaine J Carlson, Travis R Taylor, Melanie de la Cruz, Susan J Johns, Doug Stryke, Michiko Kawamoto, Thomas J Urban, Deanna L Kroetz, Thomas E Ferrin, Andrew G Clark, Neil Risch, Ira Herskowitz, Kathleen M Giacomini, Pharmacogenetics Of Membrane Transporters Investigators

Author Affiliations

1: Department of Biopharmaceutical Sciences, University of California, San Francisco, CA 94143-0446, USA.

Articles citing this

SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res (2003) 52.26

Genetic variation in an individual human exome. PLoS Genet (2008) 6.68

Medical sequencing at the extremes of human body mass. Am J Hum Genet (2007) 5.61

Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet (2010) 5.44

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest (2007) 4.47

Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. J Clin Oncol (2009) 2.47

The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci U S A (2003) 2.03

MODBASE, a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res (2008) 2.02

Pharmacogenomics: challenges and opportunities. Ann Intern Med (2006) 1.96

Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Natl Acad Sci U S A (2008) 1.47

Metformin exhibits preventive and therapeutic efficacy against experimental cystic echinococcosis. PLoS Negl Trop Dis (2017) 1.40

Conserved ERAD-like quality control of a plant polytopic membrane protein. Plant Cell (2004) 1.39

Human genetic variation recognizes functional elements in noncoding sequence. Genome Res (2009) 1.33

Comparison of human solute carriers. Protein Sci (2010) 1.29

Functional genomics of membrane transporters in human populations. Genome Res (2005) 1.27

Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2. Hum Genet (2004) 1.27

The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene. J Pharmacol Exp Ther (2008) 1.23

Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function. Pharmacogenomics J (2009) 1.18

Sequence variation in G-protein-coupled receptors: analysis of single nucleotide polymorphisms. Nucleic Acids Res (2005) 1.12

Structural imperatives impose diverse evolutionary constraints on helical membrane proteins. Proc Natl Acad Sci U S A (2009) 1.08

ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut (2005) 1.08

Novel variants in human Aquaporin-4 reduce cellular water permeability. Hum Mol Genet (2008) 1.04

Natural variation in four human collagen genes across an ethnically diverse population. Genomics (2008) 1.03

Selecting optimum eukaryotic integral membrane proteins for structure determination by rapid expression and solubilization screening. J Mol Biol (2008) 1.02

The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology. Clin Pharmacol Ther (2009) 1.01

Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5). J Pharmacol Exp Ther (2009) 1.01

Regulation of organic cation transport. Pflugers Arch (2004) 0.98

Pharmacogenetics of Anti-Diabetes Drugs. Pharmaceuticals (Basel) (2010) 0.97

Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation. PLoS One (2009) 0.96

Pharmacogenetic pathway analysis of irinotecan. Clin Pharmacol Ther (2008) 0.95

Molecular modeling and ligand docking for solute carrier (SLC) transporters. Curr Top Med Chem (2013) 0.95

Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters. Br J Clin Pharmacol (2006) 0.95

Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2). J Pharmacol Exp Ther (2008) 0.94

Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Pharmacogenet Genomics (2010) 0.93

Substrate-dependent effects of human ABCB1 coding polymorphisms. J Pharmacol Exp Ther (2008) 0.92

Identification of FZD4 and LRP5 mutations in 11 of 49 families with familial exudative vitreoretinopathy. Mol Vis (2012) 0.91

Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region. BMC Genomics (2006) 0.91

Multiplexed variation scanning for 1,000 amplicons in hundreds of patients using mismatch repair detection (MRD) on tag arrays. Proc Natl Acad Sci U S A (2005) 0.90

Diagnosis of ABCB11 gene mutations in children with intrahepatic cholestasis using high resolution melting analysis and direct sequencing. Mol Med Rep (2014) 0.89

A survey of integral alpha-helical membrane proteins. J Struct Funct Genomics (2009) 0.89

Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression. Pharmacogenomics J (2012) 0.89

Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology. Biomed Res Int (2013) 0.87

Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. PLoS One (2011) 0.87

The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy. Acta Pharmacol Sin (2013) 0.85

OCT1 and imatinib transport in CML: is it clinically relevant? Leukemia (2015) 0.84

A genome-wide scan of 10 000 gene-centric variants and colorectal cancer risk. Eur J Hum Genet (2009) 0.84

Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains. Protein Sci (2010) 0.83

Genetic variation in drug transporters in ethnic populations. Clin Pharmacol Ther (2008) 0.82

Genetic variants of human organic anion transporter 4 demonstrate altered transport of endogenous substrates. Am J Physiol Renal Physiol (2010) 0.81

Metformin increases plasma ghrelin in Type 2 diabetes. Br J Clin Pharmacol (2009) 0.80

Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications. Hum Genet (2013) 0.80

Institutional Profile: The University of California Pharmacogenomics Center: at the interface of genomics, biological mechanisms and drug therapy. Pharmacogenomics (2009) 0.80

Pharmacogenomics of membrane transporters: past, present and future. Pharmacogenomics (2010) 0.80

Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene. Mol Autism (2014) 0.79

Genetic variation of COLEC10 and COLEC11 and association with serum levels of collectin liver 1 (CL-L1) and collectin kidney 1 (CL-K1). PLoS One (2015) 0.79

Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics. Curr Psychiatry Rep (2007) 0.78

Plasma membrane transporters in modern liver pharmacology. Scientifica (Cairo) (2012) 0.78

Estimation of biliary excretion of foreign compounds using properties of molecular structure. AAPS J (2013) 0.78

A simple method for analyzing exome sequencing data shows distinct levels of nonsynonymous variation for human immune and nervous system genes. PLoS One (2012) 0.77

Topoisomerase II beta expression level correlates with doxorubicin-induced apoptosis in peripheral blood cells. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.77

Genetic polymorphisms and haplotypes of the organic cation transporter 1 gene (SLC22A1) in the Xhosa population of South Africa. Genet Mol Biol (2014) 0.76

Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1. Genome Med (2015) 0.75

Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase. ACS Med Chem Lett (2013) 0.75

Genome-wide association studies and cancer. Hawaii Med J (2010) 0.75

Genetic variation within the Mx gene of commercially selected chicken lines reveals multiple haplotypes, recombination and a protein under selection pressure. PLoS One (2014) 0.75

Articles cited by this

Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics (1989) 73.50

Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A (1992) 61.33

The structure of haplotype blocks in the human genome. Science (2002) 50.88

Predicting deleterious amino acid substitutions. Genome Res (2001) 28.95

Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet (1999) 24.24

Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet (1999) 17.09

Amino acid difference formula to help explain protein evolution. Science (1974) 15.19

A mutation data matrix for transmembrane proteins. FEBS Lett (1994) 13.49

DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet (1998) 11.70

Haplotype variation and linkage disequilibrium in 313 human genes. Science (2001) 8.52

Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet (1998) 7.56

Positive and negative selection on the human genome. Genetics (2001) 7.25

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 7.04

Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol (1999) 6.62

Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet (1993) 4.93

Nonrandomness of point mutation as reflected in nucleotide substitutions in pseudogenes and its evolutionary implications. J Mol Evol (1984) 4.42

Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet (2001) 3.95

Spontaneous mutation. Annu Rev Genet (1991) 2.15

Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet (2001) 2.07

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci U S A (2003) 2.03

Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption. Nat Genet (1996) 1.85

Selective constraints, amino acid composition, and the rate of protein evolution. Mol Biol Evol (2000) 1.63

Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics (2001) 1.49

Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry (1995) 1.33

Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population. J Hum Genet (2002) 1.08

Articles by these authors

UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47

Finding the missing heritability of complex diseases. Nature (2009) 67.95

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47

The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36

Evolution of genes and genomes on the Drosophila phylogeny. Nature (2007) 18.01

Genome-wide associations of gene expression variation in humans. PLoS Genet (2005) 17.27

Evolutionary and biomedical insights from the rhesus macaque genome. Science (2007) 16.21

Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet (2003) 13.60

Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures. Nature (2007) 11.66

Natural selection on protein-coding genes in the human genome. Nature (2005) 10.84

Assessing the evolutionary impact of amino acid mutations in the human genome. PLoS Genet (2008) 8.92

Membrane transporters in drug development. Nat Rev Drug Discov (2010) 8.56

Comparative genome sequencing of Drosophila pseudoobscura: chromosomal, gene, and cis-element evolution. Genome Res (2005) 8.38

A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol (2005) 8.32

The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med (2003) 7.94

Demographic history and rare allele sharing among human populations. Proc Natl Acad Sci U S A (2011) 7.36

WGAViewer: software for genomic annotation of whole genome association studies. Genome Res (2008) 7.15

Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry (2011) 6.98

Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci U S A (2002) 6.95

Admixture mapping for hypertension loci with genome-scan markers. Nat Genet (2005) 6.78

Proportionally more deleterious genetic variation in European than in African populations. Nature (2008) 6.61

Evolution of transcription factor binding sites in Mammalian gene regulatory regions: conservation and turnover. Mol Biol Evol (2002) 6.44

Genomic scans for selective sweeps using SNP data. Genome Res (2005) 6.43

Evolutionary changes in cis and trans gene regulation. Nature (2004) 6.24

Whole-genome shotgun assembly and comparison of human genome assemblies. Proc Natl Acad Sci U S A (2004) 6.08

Reconstructing genetic ancestry blocks in admixed individuals. Am J Hum Genet (2006) 5.92

Visualizing density maps with UCSF Chimera. J Struct Biol (2006) 5.75

Recent explosive human population growth has resulted in an excess of rare genetic variants. Science (2012) 5.58

A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set. Am J Hum Genet (2003) 5.34

Localizing recent adaptive evolution in the human genome. PLoS Genet (2007) 5.11

BayGenomics: a resource of insertional mutations in mouse embryonic stem cells. Nucleic Acids Res (2003) 4.83

Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A (2008) 4.76

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature (2010) 4.64

Recent and ongoing selection in the human genome. Nat Rev Genet (2007) 4.62

MODBASE, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res (2004) 4.54

Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide. Science (2003) 4.48

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest (2007) 4.47

The functional spectrum of low-frequency coding variation. Genome Biol (2011) 4.42

Deep resequencing reveals excess rare recent variants consistent with explosive population growth. Nat Commun (2010) 4.39

Development and implementation of high-throughput SNP genotyping in barley. BMC Genomics (2009) 4.23

Transcriptome-wide identification of novel imprinted genes in neonatal mouse brain. PLoS One (2008) 4.03

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med (2006) 3.90

Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68

Reconstituting the frequency spectrum of ascertained single-nucleotide polymorphism data. Genetics (2004) 3.65

Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies. Nat Genet (2006) 3.54

A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet (2002) 3.52

Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. Am J Public Health (2005) 3.50

Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet (2004) 3.47

The International Gene Trap Consortium Website: a portal to all publicly available gene trap cell lines in mouse. Nucleic Acids Res (2006) 3.40

Linkage disequilibrium and the mapping of complex human traits. Trends Genet (2002) 3.38

Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet (2009) 3.33

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci U S A (2002) 3.28

Regulatory changes underlying expression differences within and between Drosophila species. Nat Genet (2008) 3.24

Population stratification confounds genetic association studies among Latinos. Hum Genet (2005) 3.19

Designed divergent evolution of enzyme function. Nature (2006) 3.09

Dynamic evolution of the innate immune system in Drosophila. Nat Genet (2007) 3.09

Homozygosity and linkage disequilibrium. Genetics (2002) 3.04

Using sequence similarity networks for visualization of relationships across diverse protein superfamilies. PLoS One (2009) 3.03

Darwinian and demographic forces affecting human protein coding genes. Genome Res (2009) 3.01

ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res (2010) 2.96

Polo-like kinase Cdc5 promotes chiasmata formation and cosegregation of sister centromeres at meiosis I. Nat Cell Biol (2003) 2.94

Unique and redundant roles for HOG MAPK pathway components as revealed by whole-genome expression analysis. Mol Biol Cell (2003) 2.92

Genes regulated by mating, sperm, or seminal proteins in mated female Drosophila melanogaster. Curr Biol (2004) 2.84

Y chromosome of D. pseudoobscura is not homologous to the ancestral Drosophila Y. Science (2004) 2.80

Control of landmark events in meiosis by the CDK Cdc28 and the meiosis-specific kinase Ime2. Genes Dev (2003) 2.79

Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet (2008) 2.71

Genomic priorities and public health. Science (2003) 2.69

Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics (2005) 2.68

Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep (2007) 2.68

Leveraging enzyme structure-function relationships for functional inference and experimental design: the structure-function linkage database. Biochemistry (2006) 2.65

Thrice out of Africa: ancient and recent expansions of the honey bee, Apis mellifera. Science (2006) 2.64

Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet (2010) 2.61

clusterMaker: a multi-algorithm clustering plugin for Cytoscape. BMC Bioinformatics (2011) 2.56

Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res (2011) 2.52

Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. J Clin Oncol (2009) 2.47

Population genetic analysis of shotgun assemblies of genomic sequences from multiple individuals. Genome Res (2008) 2.46

Yeast go the whole HOG for the hyperosmotic response. Trends Genet (2002) 2.45

Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. Am J Trop Med Hyg (2006) 2.43

Tools for integrated sequence-structure analysis with UCSF Chimera. BMC Bioinformatics (2006) 2.38

Genetic basis of natural variation in D. melanogaster antibacterial immunity. Science (2004) 2.38

Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Res (2006) 2.37

Evolution of protein-coding genes in Drosophila. Trends Genet (2008) 2.36

Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol Cell Biol (2007) 2.33

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov (2007) 2.32

Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. Genomics (2011) 2.31

Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet (2005) 2.26

Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol (2009) 2.20